In a joint effort with UMCG, University of Groningen and several international partners, PureIMS is actively battling the COVID-19 pandemic by repurposing hydroxychloroquine for pulmonary administration. A first in man trial with Hydroxychloroquine Cyclops™ is in preparation. Nevertheless, it will take months if not longer before this product will become available, if proven effective.
We are experiencing a lot of spontaneous help in our efforts, which is truly motivating and heartwarming. Please understand that we truly are very grateful for all your offers, despite that we may not be able to respond to all your offerings in these extraordinary times.